Tenaya Therapeutics (TNYA) awards director 120,000 options at $0.7989
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tenaya Therapeutics director Deepak Srivastava received a grant of stock options for 120,000 shares of common stock at an exercise price of $0.7989 per share. The options vest in full on May 28, 2027, or earlier immediately before the next annual stockholder meeting, if he continues as a service provider. The options expire on May 27, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Srivastava Deepak
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 120,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to buy) — 120,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 120,000 shares
Exercise price: $0.7989 per share
Underlying shares: 120,000 shares
+3 more
6 metrics
Option grant size
120,000 shares
Stock Option (Right to buy) grant
Exercise price
$0.7989 per share
Conversion or exercise price for options
Underlying shares
120,000 shares
Common stock underlying the options
Shares following transaction
120,000 options
Total derivative securities held after grant
Vesting date
May 28, 2027
Full vesting or earlier before next annual meeting
Expiration date
May 27, 2036
Option term end date
Key Terms
Stock Option (Right to buy), Equity Incentive Plan, vesting, service provider
4 terms
Stock Option (Right to buy) financial
"security_title: "Stock Option (Right to buy)""
Equity Incentive Plan financial
"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
service provider financial
"subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date"
FAQ
What did Tenaya Therapeutics (TNYA) director Deepak Srivastava receive in this Form 4?
He received a grant of stock options for 120,000 shares of common stock. These options are part of Tenaya’s 2021 Equity Incentive Plan and represent compensation rather than an open-market share purchase.
What is the exercise price of Deepak Srivastava’s new Tenaya (TNYA) options?
The options have an exercise price of $0.7989 per share. This is the price at which he can buy Tenaya common stock once the options vest, regardless of the future market price.
When do Deepak Srivastava’s Tenaya (TNYA) stock options vest?
The options vest in full on May 28, 2027, or earlier immediately before the next annual meeting of stockholders after the grant date, if he continues as a service provider until that time.
When do the stock options granted to Deepak Srivastava expire at Tenaya (TNYA)?
The options expire on May 27, 2036. After this date, any unexercised portion of the 120,000-share option grant will no longer be exercisable by the reporting person.
Is Deepak Srivastava’s Tenaya (TNYA) Form 4 a market buy or sell?
No, it reports a grant of stock options, not an open-market trade. The transaction is coded as a grant or award (code A), reflecting equity compensation, with no shares bought or sold in the market.